These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35562271)

  • 1. Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].
    Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
    Int Immunopharmacol; 2022 Jul; 108():108844. PubMed ID: 35562271
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].
    Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
    Int Immunopharmacol; 2020 Sep; 86():106796. PubMed ID: 32674050
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.
    Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
    Int Immunopharmacol; 2015 Sep; 28(1):34-43. PubMed ID: 26002585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to 'In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects' [Int. Immunopharmacol. 87 (2020) 106787].
    Ma W; Zhang Y; Yu M; Wang B; Xu S; Zhang J; Li X; Ye X
    Int Immunopharmacol; 2020 Nov; 88():106899. PubMed ID: 32827917
    [No Abstract]   [Full Text] [Related]  

  • 5. Sustained release effects of berberine-loaded chitosan microspheres on in vitro chondrocyte culture.
    Zhou Y; Liu S; Ming J; Li Y; Deng M; He B
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1703-1714. PubMed ID: 28585864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Anti-arthritis effect of berberine associated with regulating energy metabolism of macrophages through AMPK/HIF-1α pathway". [Int. Immunopharmacol. 87 (2020) 106830].
    Yu Y; Cai W; Zhou J; Lu H; Wang Y; Song Y; He R; Pei F; Wang X; Zhang R; Liu H; Wei F
    Int Immunopharmacol; 2021 Oct; 99():107911. PubMed ID: 34353734
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Berberine regulates PADI4-related macrophage function to prevent lung cancer" [Int. Immunopharmacol. 110 (2022) 108965].
    Gu W; Zhang M; Gao F; Niu Y; Sun L; Xia H; Li W; Zhang Y; Guo Z; Du G
    Int Immunopharmacol; 2023 Jul; 120():110366. PubMed ID: 37258402
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Monotropein exerts protective effects against IL-1β-induced apoptosis and catabolic responses on osteoarthritis chondrocytes" [Int. Immunopharmacol. 23(2) (2014) 575-580].
    Wang F; Wu L; Li L; Chen S
    Int Immunopharmacol; 2023 Mar; 116():109633. PubMed ID: 36780829
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Berberine derivative DCZ0358 induced oxidative damage by ROS-mediated JNK signaling in DLBCL cells" [Int. Immunopharmacol. 125(Part A) (2023) 111139].
    Feng Q; Hu K; Hu H; Lu Y; Zhang H; Wang G; Zhang Q; Xu Z; Gao X; Jia X; Zhu H; Song D; Yi H; Peng Y; Wu X; Li B; Zhu W; Shi J
    Int Immunopharmacol; 2024 Aug; 137():112499. PubMed ID: 38909009
    [No Abstract]   [Full Text] [Related]  

  • 10. Berberine Hydrochloride-Loaded Chitosan Nanoparticles Effectively Targets and Suppresses Human Nasopharyngeal Carcinoma.
    Wang Y; Wen B; Yu H; Ding D; Zhang J; Zhang Y; Zhao L; Zhang W
    J Biomed Nanotechnol; 2018 Aug; 14(8):1486-1495. PubMed ID: 29903063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Alpha-Mangostin suppresses interleukin-1β-induced apoptosis in rat chondrocytes by inhibiting the NF-κB signaling pathway and delays the progression of osteoarthritis in a rat model" [Int. Immunopharmacol. 52 (2017) 156-162].
    Pan T; Chen R; Wu D; Cai N; Shi X; Li B; Pan J
    Int Immunopharmacol; 2018 Dec; 65():559-560. PubMed ID: 30412853
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice" [Int. Immunopharmacol. 59 (2018) 269-275].
    Luo S; Deng X; Liu Q; Pan Z; Zhao Z; Zhou L; Luo X
    Int Immunopharmacol; 2018 Sep; 62():337. PubMed ID: 29983242
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and characterization of berberine-loaded chitosan nanoparticles for the protection of urethane-induced lung cancer.
    Mahmoud MA; El-Bana MA; Morsy SM; Badawy EA; Farrag AE; Badawy AM; Abdel-Wahhab MA; El-Dosoky MA
    Int J Pharm; 2022 Apr; 618():121652. PubMed ID: 35278602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan/hyaluronic acid polymer blending for sustained release of berberine.
    Lu KY; Lin YC; Lu HT; Ho YC; Weng SC; Tsai ML; Mi FL
    Carbohydr Polym; 2019 Feb; 206():664-673. PubMed ID: 30553371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.
    Lin YH; Lin JH; Chou SC; Chang SJ; Chung CC; Chen YS; Chang CH
    Nanomedicine (Lond); 2015 Jan; 10(1):57-71. PubMed ID: 25177920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of fucoidan-shelled and genipin-crosslinked chitosan beads for antibacterial application.
    Yu SH; Wu SJ; Wu JY; Wen DY; Mi FL
    Carbohydr Polym; 2015 Aug; 126():97-107. PubMed ID: 25933528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432].
    Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
    Int Immunopharmacol; 2016 Jun; 35():341. PubMed ID: 27130814
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice" [Int. Immunopharmacol. 24 (2015) 383-391].
    Shieh YH; Huang HM; Ching-Chiung Wang ; Lee CC; Fan CK; Lee YL
    Int Immunopharmacol; 2017 Sep; 50():371. PubMed ID: 28751107
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways". [Int. Immunopharmacol. 66 (2019) 41-51].
    Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
    Int Immunopharmacol; 2020 Feb; 79():106117. PubMed ID: 31862426
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].
    Wen S; Wei Y; Zhang X; Bai F; Tan S; Nie J; Wei J; Lin X
    Int Immunopharmacol; 2021 Mar; 92():107344. PubMed ID: 33418247
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.